We are a biopharmaceutical company focused on the discovery, development, and commercialization of HOCl therapeutics.

Joined July 2014
We believe there are several potential advantages of RUT58-60 over systemic #antibiotics. Find out more: ow.ly/COskq #infection
3
3
In vitro studies with RUT58-60 have demonstrated complete bacterial destruction in 30 seconds. #FactoftheDay #antibioticresistance $RTGN
3
1
#Blogpost: Evolution and Bacteria: The role of selective pressure in #antibioticresistance. ow.ly/Gn4vv #science #surgery
2
1
"The development of new #antibiotics has failed to keep pace with the rise in #superbugs..." Read more on @FT. ow.ly/FUZvE
RUT58-60 mechanism of action: HOCI cross-links bacterial biomolecules on cell surfaces via oxidation reaction. $RTGN
4
2
RUT58-60, if approved, could be the only prepackaged, sterilized, ready-to-use HOCI-based drug intended for #infection control in surgery.
1
1
Have you checked out our investors' hub online? Be sure to take a look, for more info: ir.ruthigen.com/ #investment $RTGN
RUT58-60, if approved, could be the only prepackaged, sterilized, ready-to-use HOCI-based drug intended for #infection control in surgery.
HOCI, the active ingredient in RUT58-60, mimics the body’s natural microbe-fighting mechanism. $RTGN #antibioticresistance
Potential $RTGN advantages over #antibiotics: Broad Range Anti-Infective, Addresses Resistance Concerns, Pro-Healing. #antibioticresistance
Ruthigen CFO Sameer Harish stresses the economic benefits from reducing hospital readmissions & reimbursement. $RTGN
1
1
Our CFO featured on @biotuesday: "Ruthigen nears #clinical milestone with anti-infective drug." #infectiousdisease ow.ly/ES3Aq
2
1
Mon. (11/24) 8:30a.m. EST @Ruthigen CEO Hoji Alimi speaks with Kevin Price @KevinPriceLive on the @KTEKHouston Bloomberg radio affiliate
We strongly believe in the efforts of the CDC through #AntibioticDay, & have contributions to the efforts w/RUT58-60: ruthigen.com/product/
Ruthigen Inc. retweeted
Time to get smart...about antibiotics. The @CDCgov has the information you need: 1.usa.gov/1yNvYix
1
16
5
RUT58-60 addresses antibiotic resistance because it is effective against harmful antibiotic-resistant bacteria such as MRSA. #AntibioticDay
1
1